Mohamed Ali Bahri

Mohamed Ali Bahri

Auto-generated profile, based on publicly available information

Mohamed Ali Bahri

University of Liège

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2023 in Science Advances
Verified
Journal Article
Open access
ALAndrea I. Luppi
Andrea I. Luppi
JHJustine Y. Hansen
Justine Y. Hansen
RARam Adapa
Ram Adapa
RCRobin L. Carhart-Harris
Robin L. Carhart-Harris
LRLeor Roseman
Leor Roseman
ESEmmanuel A. Stamatakis
Emmanuel A. Stamatakis
To understand how pharmacological interventions can exert their powerful effects on brain function, we need to understand how they engage the brain’s rich neurotransmitter landscape. Here, we bridge microscale molecular chemoarchitecture and pharmacologically induced macroscale functional reorganization, by relating the regional distribution of 19 neurotransmitter receptors and transporters obtained from positron emission tomography, and the regional changes in functional magnetic resonance imaging connectivity induced by 10 different mind-altering drugs: propofol, sevoflurane, ketamine, lysergic acid diethylamide (LSD), psilocybin, N,N-Dimethyltryptamine (DMT), ayahuasca, 3,4-methylenedioxymethamphetamine (MDMA), modafinil, and methylphenidate. Our results reveal a many-to-many mapping between psychoactive drugs’ effects on brain function and multiple neurotransmitter systems. The effects of both anesthetics and psychedelics on brain function are organized along hierarchical gradients of brain structure and function. Last, we show that regional co-susceptibility to pharmacological interventions recapitulates co-susceptibility to disorder-induced structural alterations. Collectively, these results highlight rich statistical patterns relating molecular chemoarchitecture and drug-induced reorganization of the brain’s functional architecture.

1 September 2020 in Brain Connectivity
Verified
Journal Article
Closed access
Manon CarrièreManon Carrière
Manon Carrière
SLStephen Karl Larroque
Stephen Karl Larroque
Charlotte MartialCharlotte Martial
Charlotte Martial
MBMohamed Ali Bahri
Mohamed Ali Bahri
CACharlène Aubinet
Charlène Aubinet
LHLizette Heine
Lizette Heine
Background Given its emotional and autobiographical properties, music appears as a potential aid in diagnostic assessment and therapeutics in patients with disorders of consciousness (DOC). Several studies have shown boosting effects on behavior and brain functioning when patients were exposed to (their preferred) music. Objective To investigate if these effects on the brain’s spontaneous activity are dependent on the level of consciousness. Methods Nine post-comatose patients and eight healthy control subjects were assessed using fMRI in two conditions: rest (without stimulation) and music. All patients presented at least an auditory startle, thereby suggesting the presence of residual auditory function. A gradient of consciousness (from unresponsive wakefulness syndrome to healthy subjects) was formulated to evaluate consciousness-level-dependent increases in brain activity and connectivity. Network-based functional connectivity assessed auditory, default-mode, frontoparietal and music-evoked emotions networks. Furthermore, exploratory voxel-to-voxel analyses were performed at the whole brain level using intrinsic connectivity contrast and (fractional) amplitude of low frequency fluctuations. Results Stronger consciousness-level-dependent increases within network-to-voxel analysis of connectivity were found in the frontoparietal network with the precuneus during music stimulation compared to rest. Voxel-to-voxel analyses showed stronger increases of intrinsic connectivity in the music condition compared to rest in regions previously related to music processing. There were consistently more regions with increased connectivity during the main effect of music compared to rest. These increases of connectivity during music were observed in brain regions involved in consciousness, language, emotion and memory processing. Conclusions Our results show that music seems to trigger more substantial connectivity changes compared to rest, pointing towards the potential ability of music to stimulate patients’ brain function. Further research should focus on effects of music in general, its specific acoustical features and the effects of simple auditory stimuli, as well as the possible therapeutic and diagnostic effects of music in well controlled clinical trials.

14 May 2020 in Molecules
Verified
Journal Article
Open access
PDF file
GBGuillaume Becker
Guillaume Becker
SDsylvestre dammicco
sylvestre dammicco
MBMohamed Ali Bahri
Mohamed Ali Bahri
ESEric Salmon
Eric Salmon
Many neurological disorders are related to synaptic loss or pathologies. Before the boom of positrons emission tomography (PET) imaging of synapses, synaptic quantification could only be achieved in vitro on brain samples after autopsy or surgical resections. Until the mid-2010s, electron microscopy and immunohistochemical labelling of synaptic proteins were the gold-standard methods for such analyses. Over the last decade, several PET radiotracers for the synaptic vesicle 2A protein have been developed to achieve in vivo synapses visualization and quantification. Different strategies were used, namely radiolabelling with either 11C or 18F, preclinical development in rodent and non-human primates, and binding quantification with different kinetic modelling methods. This review provides an overview of these PET tracers and underlines their perspectives and limitations by focusing on radiochemical aspects, as well as preclinical proof-of-concept and the main clinical outcomes described so far.

22 December 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
DCDaphne Chylinski
Daphne Chylinski
MEMaxime Van Egroo
Maxime Van Egroo
JNJustinas Narbutas
Justinas Narbutas
MGMartin Grignard
Martin Grignard
EKEkaterina Koshmanova
Ekaterina Koshmanova
Gilles VandewalleGilles Vandewalle
Gilles Vandewalle
BACKGROUND: Tight relationships between sleep quality, cognition, and amyloid-β (Aβ) accumulation, a hallmark of Alzheimer’s disease (AD) neuropathology, have been shown. Sleep arousals become more prevalent with aging and are considered to reflect poorer sleep quality. However, heterogeneity in arousals has been suggested while their associations with Aβ and cognition are not established. METHODS: We recorded undisturbed night-time sleep with EEG in 101 healthy individuals aged 50–70 years, devoid of cognitive and sleep disorders. We classified spontaneous arousals according to their association with muscular tone increase (M+/M–) and sleep stage transition (T+/T–). We assessed cortical Aβ burden over earliest affected regions via PET imaging and assessed cognition via neuropsychological testing. RESULTS: Arousal types differed in their oscillatory composition in θ (4–8 Hz) and β (16–30 Hz) EEG bands. Furthermore, T+M– arousals, interrupting sleep continuity, were positively linked to Aβ burden ( P = 0.0053, R² β * = 0.08). By contrast, more prevalent T–M+ arousals, upholding sleep continuity, were associated with lower Aβ burden ( P = 0.0003, R² β * = 0.13), and better cognition, particularly over the attentional domain ( P < 0.05, R² β * ≥ 0.04). CONCLUSION: Contrasting with what is commonly accepted, we provide empirical evidence that arousals are diverse and differently associated with early AD-related neuropathology and cognition. This suggests that sleep arousals, and their coalescence with other brain oscillations during sleep, may actively contribute to the beneficial functions of sleep and constitute markers of favorable brain and cognitive health trajectories. TRIAL REGISTRATION: EudraCT 2016-001436-35. FUNDING: FRS-FNRS Belgium (FRSM 3.4516.11), Actions de Recherche Concertées Fédération Wallonie-Bruxelles (SLEEPDEM 17/27-09), ULiège, and European Regional Development Fund (Radiomed Project).

9 August 2023 in Neurobiology of Aging
Verified
Journal Article
Closed access
SMSoodeh Moallemian
Soodeh Moallemian
ESEric Salmon
Eric Salmon
MBMohamed Ali Bahri
Mohamed Ali Bahri
NBNikita Beliy
Nikita Beliy
EDEmma Delhaye
Emma Delhaye
CBChristine Bastin
Christine Bastin

25 January 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
MEMaxime Van Egroo
Maxime Van Egroo
DCDaphne Chylinski
Daphne Chylinski
JNJustinas Narbutas
Justinas Narbutas
GBGabriel Besson
Gabriel Besson
VMVincenzo Muto
Vincenzo Muto
Gilles VandewalleGilles Vandewalle
Gilles Vandewalle
BACKGROUND: Neuronal hyperexcitability characterizes the early stages of Alzheimer’s disease (AD). In animals, early misfolded tau and amyloid-β (Aβ) protein accumulation — both central to AD neuropathology — promote cortical excitability and neuronal network dysfunction. In healthy humans, misfolded tau and Aβ aggregates are first detected, respectively, in the brainstem and frontomedial and temporobasal cortices, decades prior to the onset of AD cognitive symptoms. Whether cortical excitability is related to early brainstem tau — and its associated neuroinflammation — and cortical Aβ aggregations remains unknown. METHODS: We probed frontal cortex excitability, using transcranial magnetic stimulation combined with electroencephalography, in a sample of 64 healthy late-middle–aged individuals (50–69 years; 45 women and 19 men). We assessed whole-brain [18F] THK5351 PET uptake as a proxy measure of tau/neuroinflammation, and we assessed whole-brain Aβ burden with [18F] Flutemetamol or [18F] Florbetapir radiotracers. RESULTS: We found that higher [18F] THK5351 uptake in a brainstem monoaminergic compartment was associated with increased cortical excitability ( r = 0.29, P = 0.02). By contrast, [18F] THK5351 PET signal in the hippocampal formation, although strongly correlated with brainstem signal in whole-brain voxel-based quantification analyses ( P value corrected for family-wise error [ P FWE-corrected ] < 0.001), was not significantly associated with cortical excitability ( r = 0.14, P = 0.25). Importantly, no significant association was found between early Aβ cortical deposits and cortical excitability ( r = –0.20, P = 0.11). CONCLUSION: These findings reveal potential brain substrates for increased cortical excitability in preclinical AD and may constitute functional in vivo correlates of early brainstem tau accumulation and neuroinflammation in humans. TRIAL REGISTRATION: EudraCT 2016-001436-35. FUNDING: F.R.S.-FNRS Belgium, Wallonie-Bruxelles International, ULiège, Fondation Simone et Pierre Clerdent, European Regional Development Fund.